<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<meta name="format-detection" content="telephone=no">
<title>FORTEO® teriparatide (rDNA origin) injection | DEC,2022</title>
<style>
html{
    background:#F8F6F5}
body{
    width: 100%;
	margin:0;
	padding:0;
    font-family:'Microsoft JhengHei','PingFangTC-Regular', 'Arial', 'Helvetica', sans-serif}
tr,
td{ margin:0;
	padding:0;}
img{
    display:block;
    margin: 0;
    padding: 0;
	border:0}
</style>
</head>


<body>
    <table width="640" cellspacing="0" cellpadding="0" style="margin: 0 auto; background-color: #eee; border-collapse: collapse;">
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-14_01.png" width="640" height="106" style="display:block;outline:0;border:0" alt="FORTEO® teriparatide (rDNA origin) injection">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-14_02.png" width="640" height="132" style="display:block;outline:0;border:0" alt="UK clinical guideline for the prevention and treatment of osteoporosis">
            </td>
        </tr>
        <tr style="width:100%; height: 46px;background-color: #ffffff;">
            <td style="width:100%; height: 46px; background-image:url(https://www.iprc.com.tw/edm/forteo/images/edm-14_03.png); background-repeat: no-repeat; background-size: cover">
                <p style="display:block; font-family:Helvetica, 'Microsoft JhengHei','PingFangTC-Regular', 'Arial', sans-serif; font-weight: bold; font-size: 18px; color:#0f3767; line-height: 0; padding:0 0 0 40px; vertical-align: middle;">Dear Dr. {{accLname}} {{accFname}} {{accTitle}},</p>
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-14_04.png" width="640" height="100" style="display:block;outline:0;border:0" alt="The National Osteoporosis Guideline Group (NOGG) has revised the UK guideline for the assessment and management of osteoporosis and the prevention of fragility fractures in postmenopausal women, and men age 50 years and older.">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-14_05.png" width="640" height="69" style="display:block;outline:0;border:0" alt="Accredited by NICE, this guideline is relevant for all healthcare professionals involved in osteoporosis management.">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-14_06.png" width="640" height="120" style="display:block;outline:0;border:0" alt="The drugs listed have been shown to reduce fragility fractures in postmenopausal women, and men where indicated, with osteoporosis by evidence level">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-14_07.png" width="640" height="81" style="display:block;outline:0;border:0" alt="Table 5 Anti-fracture efficacy of approved drug treatments for postmenopausal women, and men, with osteoporosis when given with calcium and vitamin D">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-14_08.png" width="640" height="207" style="display:block;outline:0;border:0" alt="Table 5 Anti-fracture efficacy of approved drug treatments for postmenopausal women, and men, with osteoporosis when given with calcium and vitamin D">
            </td>
        </tr>
        <tr>
            <td><a href="https://link.springer.com/article/10.1007/s11657-022-01061-5" target="_blank" title="Learn more about reducing fracture risk?
                Find more here!" rel="noreferrer noopener">
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-14_09.png" width="640" height="105" style="display:block;outline:0;border:0" alt="" >
                </a>
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-14_10.png" width="640" height="125" style="display:block;outline:0;border:0" alt="QUALITY OF BONE QUALITY OF LIFE">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-14_11.png" width="640" height="150" style="display:block;outline:0;border:0" alt="骨穩® 注射液 Forteo (teriparatide) For Injection">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-14_12.png" width="640" height="99" style="display:block;outline:0;border:0" alt="P-MKT-RP-036-22-Dec-24">
            </td>
        </tr>
        <tr>
            <td style="padding: 15px 0 15px 0; background:#ffffff">
                <div style="font-family:sans-serif">
                    <div class="txtTinyMce-wrapper" style="font-size:12px;mso-line-height-alt:16.8px;color:#737372;line-height:18px;font-family:Arial,Helvetica Neue,Helvetica,sans-serif">
                    <p style="margin:0;text-align:center">© 2022 Zuellig Pharma Holdings Pte. Ltd. All rights reserved.</p>
                    <p style="margin:0;text-align:center">
                        <a href="https://www.zuelligpharma.com/legal-disclaimer" target="_blank" rel="noopener" style="color: #313e5b;">Legal Disclaimer&nbsp;</a>&nbsp;|
                        <a href="https://www.zuelligpharma.com/privacy-policy" target="_blank" rel="noopener" style="color: #313e5b;">&nbsp;Privacy Policy</a>
                        |&nbsp;
                        <a href="{{unsubscribe_product_link[,ZLG_CONTENT_TYPES]}}" target="_blank" style="text-decoration: underline; color: #313e5b;" rel="noopener">&nbsp;Unsubscribe</a>&nbsp;
                    </p>
                    </div>
                </div>
            </td>
        </tr>
    </table>
</body>
</html>